Back to GSK Stock Lookup

GSK Related Mergers and Acquisitions

Mar 1, 2013 01:58 PM UPDATE: Wedbush Downgrades MAP Pharma (MAPP) to Neutral, Notes Other Potential M&A Targets

Nov 8, 2012 06:32 AM XenoPort (XNPT) Terminates Horizant Collaboration with Glaxo (GSK)

Sep 10, 2012 08:39 AM Biogen Idec (BIIB) Sells Royality, Other Rights for BENLYSTA to DRI Capital

Jul 30, 2012 08:37 AM GlaxoSmithKline (GSK) Announces Results of Initial Tender Offer for Human Genome Sciences (HGSI)

Jul 27, 2012 07:46 AM Amgen (AMGN) Said to Make $7B Bid for Human Genome (HGSI) in 2010

Jul 16, 2012 10:31 AM Baird Downgrades Human Genome Sciences (HGSI) to Neutral; Story Now Played Out

Jul 16, 2012 09:17 AM Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash

Jul 16, 2012 06:37 AM Human Genome Sciences (HGSI) Agrees to $14/Share Takeover from GSK (GSK) - Reports

Jun 29, 2012 09:11 AM Human Genome (HGSI) Says Less than 1% of Shares Tendered in Glaxo (GSK) Offer

Jun 29, 2012 07:09 AM Glaxo (GSK) Extends $13/Share Tender for Human Genome (HGSI)

Jun 29, 2012 06:59 AM Human Genome (HGSI) Could Get 15% More in Takeover Bid - Analyst

Jun 15, 2012 06:41 AM Human Genome Sciences (HGSI) Calls It; Says July 16th Deadline for Bids (GSK)

Jun 12, 2012 08:31 AM BioMarin (BMRN) Higher as Takeover Chatter Swirls

Jun 8, 2012 09:28 AM Human Genome (HGSI) Rejects $13/Share Bid from Glaxo (GSK); Calls It 'Inadequate'

Jun 8, 2012 09:27 AM Human Genome (HGSI) Comments on GlaxoSmithKline's (GSK) Announcement to Extend Tender Offer

Jun 8, 2012 08:38 AM UPDATE: GlaxoSmithKline (GSK) Extends Tender Offer for Human Genome (HGSI) to June 29th

Jun 1, 2012 01:47 PM UPDATE: Human Genome (HGSI) Rejects GSK's (GSK) $13/Share Offer

May 17, 2012 01:17 PM Glaxo (GSK) Comments on Human Genome (HGSI) Bid Rejection; Will Continue with $13/Share Tender

May 17, 2012 07:06 AM Human Genome Sciences (HGSI) Unanimously Rejects GlaxoSmithKline (GSK) Offer

May 14, 2012 03:58 PM Barclays Maintains an 'Equalweight' on Human Genome Sciences (HGSI); Looking At $15/Share For GSK To Seal The Deal

May 10, 2012 07:40 AM Leerink Swann Downgrades Human Genome Sciences (HGSI) to Market Perform; Limited Visibility

May 9, 2012 10:08 AM Human Genome Sciences (HGSI) to Review Offer from Glaxo (GSK)

May 9, 2012 06:52 AM GlaxoSmithKline (GSK) Commence $13/Share Tender Offer for Human Genome Sciences (HGSI)

Apr 19, 2012 07:44 AM Glaxo (GSK) Confirms $13/Share Offer for Human Genome Sciences (HGSI)

Apr 19, 2012 06:32 AM Human Genome (HGSI) Gets $13/Share Bid from Glaxo (GSK); to Explore Strategic Alternatives

Apr 12, 2012 11:10 AM UPDATE - UBS Initiates Coverage on Human Genome (HGSI) with a Neutral; See Stock Range-Bound as GSK Hovers

Apr 2, 2012 07:40 AM Glaxo (GSK) to Acquire Additional 10M Common Stake in Theravance (THRX) at $21.2887/Share

Mar 7, 2012 10:17 AM GlaxoSmithKline (GSK) Seeking Buyer for European Non-Core Drugs Portfolio -IBT

Dec 22, 2011 07:20 AM Glaxo (GSK) to Sell Fortaz, Parnate, Zantac, Other Rights in U.S., Puerto Rico to Covis Pharma

Dec 20, 2011 08:16 AM Prestige Brands (PBH) to Acquire 17 OTC Pharma Brands from Glaxo (GSK) in $660M Deal

Nov 28, 2011 07:33 AM POZEN (POZN) Sells Treximet Rights in $75M Deal (GSK)

Nov 9, 2011 07:34 AM Mylan (MYL) Acquires Certain Diskus Rights from Pfizer (PFE)

Oct 18, 2011 08:11 AM Glaxo (GSK) Could Bid $25/Share for Human Genome (HGSI) -UK's Mail

Feb 3, 2011 07:16 AM Valeant (VRX) Unit Pays $300M to Glaxo's (GSK) Zovirax Rights in U.S. and Canada

Nov 29, 2010 06:53 AM GlaxoSmithKline (GSK) Makes $129.38M Investment in Theravance (THRX)

Nov 23, 2010 11:37 AM GlaxoSmithKline (GSK) to Transfer U.S. Oral Penicillin Portfolio and Facility to Dr. Reddy's Labs (RDY)

Jun 10, 2010 11:17 AM GlaxoSmitKline (GSK) Announces $253M Acquisition of Laboratorios Phoenix S.A.C.yF

Apr 12, 2010 12:23 PM Abraxis Bioscience (ABII) Reportedly Puts Itself Up for Sale

Sep 14, 2009 10:48 AM Wedbush Morgan Believes Levadex and Tempo Now Make MAP Pharmaceuticals (MAPP) an Acquisition Target

Jul 22, 2009 11:34 AM GlaxoSmithKline (GSK) Completes Acquisition of Stiefel Laboratories

Apr 16, 2009 07:26 AM GlaxoSmithKline plc (GSK) and Pfizer (PFE) Announces HIV Joint Venture

Jan 7, 2009 08:54 AM GlaxoSmithKline (GSK) Completes Tender Offer for Shares of Genelabs (GNLB)

Dec 30, 2008 09:16 AM GlaxoSmithKline (GSK) Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies (GNLB)

Dec 30, 2008 08:59 AM GlaxoSmithKline (GSK) Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies

Nov 12, 2008 09:52 AM GlaxoSmithKline (GSK) Subsidiary Commences Tender Offer for Genelabs Technologies (GNLB)

Sep 10, 2008 10:19 AM Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News

Jun 6, 2008 07:26 AM GlaxoSmithKline (GSK) Acquires Sirtris Pharmaceuticals (SIRT) for $720 Million

Apr 22, 2008 04:41 PM GlaxoSmithKline (GSK) To Acquire Sirtris Pharmaceuticals (SIRT) for $22.50/Share

Feb 15, 2007 09:05 AM GlaxoSmithKline (GSK) Extends Subsequent Offering for PRAECIS (PRCS) By One Day

Jan 9, 2007 09:16 AM GlaxoSmithKline plc (GSK) Commences Tender Offer to Acquire PRAECIS Pharmaceuticals (PRCS)

Back to GSK Stock Lookup